-
公开(公告)号:US20180141991A1
公开(公告)日:2018-05-24
申请号:US15735949
申请日:2016-06-12
申请人: Yen-Ta LU , Mackay Medical Foundation The Presbyterian Church In Taiwan Mackay Memorial Hospital
发明人: Yen-Ta LU , Chia-Ming CHANG , Tsai-Yin WEI
CPC分类号: C07K16/2845 , A61K38/00 , A61K38/1774 , A61K39/3955 , A61K45/06 , A61K47/59 , A61K47/643 , A61P37/06 , C07K14/705 , C07K14/70503 , C07K2317/21 , C07K2317/24 , C07K2317/76 , C07K2319/70
摘要: A method for modulating an immunoresponse includes binding a TREM-like transcript 1 (TLT-1) polypeptide to an immune cell, wherein the binding of the TLT-1 polypeptide to the immune cell suppresses immunoresponse. A method for treating and/or preventing a disease associated with immune hyper-reactivity includes administering the TLT-1 polypeptide to a subject in need thereof.
-
公开(公告)号:US20200339557A1
公开(公告)日:2020-10-29
申请号:US16925309
申请日:2020-07-09
发明人: Yen-Ta LU , Tzenge-Lien SHIH , Chia-Ming CHANG , Tsai-Yin WEI , Jen-Wei LIU
IPC分类号: C07D417/04 , A61K31/473 , C07D413/04 , C07D209/48 , A61K31/635 , C07D221/06 , A61K31/4035 , A61K39/395 , A61K45/06 , C07D221/14 , C07K16/28
摘要: The present invention relates to benzoxazole derivatives having the following Formula (I): The compounds of the present invention are found to possess the ability to decrease PD-L1 level, suggesting that the compounds of the invention can be used in cancer immunotherapy and treatment or prevention of sepsis or septic shock.
-
公开(公告)号:US20180362651A1
公开(公告)日:2018-12-20
申请号:US15735912
申请日:2016-06-12
发明人: Yen-Ta LU , Chia-Ming CHANG , Tsai-Yin WEI , I-Fang TSAI , Ling-Chiao WU
IPC分类号: C07K16/28 , A61K45/06 , A61K39/395
摘要: A method fits reversing immune suppression or immune exhaustion or for treating a disease associated with immune suppression includes: administering a co position to a subject in need of such treatments wherein the composition contains a CD11b modulator that binds specifically to CD11b on a cell to inhibit PD-L1 expression. The CD11b modulator is an antibody or an antigen-binding portion thereof, or a compound as described.
-
-